Effect of TGP capsules combined with urokinase for the patients with acute cerebral ischemic stroke

Abstract

Objective To evaluated the effect of Total Glucosides of Paeony (TGP)combined with urokinase for the patients with acute cerebral ischemic stroke. Methods A total of 152 patients with ACIS were divided into the control group (77 patients) and the observation group (75 patients) by completely randomized grouping method. Patients in the control group were treated with Urokinase by intravenous, and the observation group were treated with TGP combined with Urokinase. All patients were treated with thrombolysis treatment with in the 24 h after the exclusion of cerebral hemorrhage by brain CT and coagulation mechanism disorder. In the following 14 days, they were given the treatment of anti platelet aggregation, lowering blood lipid, trophic nerve and improving circulation. The National Institutes of Health Stroke Scale (NIHSS), the modified Rankin scale(mRS) and the daily life ability index (Barthel) were measured. Results There were 28 (37.3%) patients with the NIHSS scores decreasing 4 points in observation group and 12 (15.6%) in control group after treatment of 7 days, and there was significant difference between two groups (χ2=8.181, P=0.004). There were 68 (90.7%) patients with mRS score less than 4 points in observation group and 51 (15.6%) in control group after treatment of 14 days, and there was significant difference between two groups (χ2=11.945, P=0.001). The NIHSS scores in the observation group was lower than control group (8.3 ± 2.2 vs. 9.9 ± 2.5; t=4.192, P<0.05). The mRS score in the observation group was lower than control group (2.3 ± 0.9 vs. 2.9 ± 1.1; t=3.684, P<0.01), and the Barthel index in the observation group was higher than the control group (88.7 ± 16.2 vs. 77.5 ± 15.2; t=4.401, P<0.01). Conclusions The TGP capsules combined with Urokinase intravenous thrombolysis could improve the neurological deficit, and the ability of daily life of ACIS patients. Key words: Brain infarction; Acute disease; Urokinase-type plasminogen activator; TGP capsules; Integrated Chinese traditional and western medicine therapy